Year: 2022
Type: review
Abstract: Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. Screening reduces CRC incidence and mortality. 2021 US Preventive Service Task Force (USPSTF) guidelines and available evidence support routine screening from ages 45 to 75, and individualized consideration of screening ages 76 to 85. USPSTF guidelines recommend annual guaiac fecal occult blood testing, annual fecal immunochemical testing (FIT), annual to every 3-year multitarget stool DNA-FIT, every 5-year sigmoidoscopy, every 10-year sigmoidoscopy with annual FIT, every 5-year computed tomographic colonography, and every 10-year colonoscopy as options for screening. The "best test is the one that gets done."
Author: Samir Gupta
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,950
Awards: CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers., CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers., G8069574821, Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and Mortality
OpenAlex ID: W4225399139